Entries in Isador Nabi (4)


When the money mines turn mouldy And the funding futures bleak,

Click to read more ...



An  Isador Nabi advanced pre-publication, pre-review, pre-approval and post marketing advisory on


                       The Multicenter Orthogenetic Replicate Trials (MORT) of Todiben™ in the treatment of Diffuse Amorphous Malaise (DAM)

Fritz Tenureman, Jason Reising, Allan Orda, Helen Wiels, Bill Pendin and Arthur Blatant


          Diffuse Amorphous Malaise (DAM) is the fastest-growing complaint among Americans above the age of six.  It is defined in the national catalog of vague disorders as an undescribable malaise in three or more body parts for more than three consecutive days in any one month, with “malaise” being any score above six on the Blaine-Fischman scale, or 15 on the Fischman-Dober scale or anything at all on the Dober-Krane scale.

          MORT studied 8112 pairs of pink identical twin nurses, or 16,225 subjects.(The odd number is due to rounding error). The participants were assigned at random to be treated with 20 mg of Todiben™ three times a day or a placebo of biochemically inert material (in this case, ground glass).  In order to avoid carryover effects from prior experience, data from the first month of the trial was discarded by means of the Polisanto Data Discarder. During this period 120 subjects in the placebo group and 96 in the treatment group dropped out of the study for a variety of reasons, the most frequently cited being death and panic.  In all such cases the remaining twin was humanely excluded from the study.  Subjects received as nominal compensation a free dinner at the Hunan-in-Boston Restaurant and Take-out.

          The study was conducted at 13 clinical centers of the Business University Research Partnership (BURP) spread out over the continental United States and some undisclosed locations in former socialist countries.  Here we report on the aggregate results of centers 3 and 8 during month 2.  In order to preserve confidentiality and proprietary information, names and numbers have been altered. The data from the other centers were destroyed by the means described above.


Two subjects in the placebo group (2.1%) and one subject in the treatment group(0.9%) reported or were diagnosed with DAM. Thus Todiben™ reduced the risk of DAM by 43%. The absence of statistical significance is most likely due to the small sample size of this subset and the overly cautious dosing.


          it is recommended that Todiben™ be used for the treatment and prevention of DAM at 60 mg per day with smaller doses for children, babies, cardiac patients more than 70 years old, and pets.



Aleph is for Abraham


           An Isador Nabi Press Release pending formal publication   in the Constantine Academy Alumni Newsletter


The renowned archeologist Isador Nabi reported today on the preliminary findings of the Summer Interfaith Field Expedition of Constantine Academy, Lootin Center, Nebraska, a course for credit designated An Introduction to Field Methods for Excavation Underneath the Mosques of the West Bank.

This year they were working near the town of Hebron. During the soldiers’ lunch break, the expedition was pelted with stones by a disorderly pack of 9 year olds on their lunch break, who then escaped into the surrounding schools. However a careful examination of the stones turned up one piece of ancient-looking clay no larger than a small fist with the hint of an inscription. The clay was later dated as 2000 B.C.E. ± 4000 years (extraneous materials of caprine origin complicated the dating). On the clay there was a diagonal crack ( when you rotate the fragment properly) that looked like \.

Our archeoscriptogapher who wishes to remain anonymous identified the diagonal as the residue of an aleph: א. Of course the letter aleph can have many uses, but around Hebron an aleph calls to mind Abraham. In fact, as our press release points out, this may be the earliest known fragment of the deed of sale giving Abraham title to Hebron, Nablus, Gath, Jericho, Ramallah, Amman, Beirut, Damascus and Baghdad. When asked for his reactions to this find, sophomore Rick Harton could only answer,”Awesome!”






Top * Writings * Categories Enable This Widget » * Ecology (1) * Isador Nabi (1) * Marxism (1) # Search # # insert new section insert new section # This container does not contain any items. configure this page post new entry add page header add page footer Friday 23Oct2009 (DRAFT) DateFriday, October 23, 2009 at 10:42PM modify remove organize post follow up # # insert new section insert new section # This container does not contain any items. configure this page post new entry add page header add page footer Friday 23Oct2009 (DRAFT) DateFriday, October 23, 2009 at 10:42PM modify remove organize post follow up QUESTIONAIRE Every once in a while the invisible hand of a polling company reaches into the virtual hat-in-the-sky and draws my name at random to ask me questions about my opinions. Sometimes, in a weak moment, I answer them. Click to read more ... AuthorRichard Levins | CommentPost a Comment | Share ArticleShare Article tagged TagIsador Nabi in CategoryIsador Nabi Friday 23Oct2009 DateFriday, October 23, 2009 at 10:35PM modify remove organize post follow up FOR THE INVESTOR AHEAD OF THE MOB (from Genewatch, newletter of the Council for Responsible Genetics) ISADOR NABI, PUBLISHER LETTER FROM THE PUBLISHER Anybody can follow a trend, extrapolate from the past and call it a prediction. All you need is a straight edge and pencil and you can pass yourself off as a financial advisor, investment counselor or Wall Street pundit. But to really be ahead of the mob you have to have a profound understanding of the potential, unrealized, invisible and latent directions. One of the truly new worlds of opportunity has not yet hit the headlines but is silently bubbling up in exclusive law offices and scientific laboratories. Only Isador Nabi is at home in both worlds and is able to see the trends before they happen. This most exciting new possibility is the patenting of emotional property.

Click to read more ...